首页 | 本学科首页   官方微博 | 高级检索  
     

药物作用新靶点:白细胞介素17及其受体
引用本文:孙创斌,胡晋红,朱全刚,刘继勇,刘艳霞. 药物作用新靶点:白细胞介素17及其受体[J]. 国际药学研究杂志, 2008, 35(3): 169-172
作者姓名:孙创斌  胡晋红  朱全刚  刘继勇  刘艳霞
作者单位:第二军医大学长海医院药学部,上海,200433
摘    要:
白细胞介素17(IL-17)是近年来新发现Th17细胞分泌的致炎细胞因子,在机体炎症及自身免疫性疾病中发挥重要作用。IL-17与其受体结合后通过信号转导而发挥作用。IL-17R-Ig融合蛋白是IL-17受体的有效抑制剂。本文综述IL-17及其受体的生物学效应、信号转导途径、与疾病的关系及药物的影响等,为IL-17及其受体作为药物作用的新靶点提供新思路。

关 键 词:白细胞介素17; 受体  白细胞介素17; 自身免疫疾病; 炎症
收稿时间:2007-10-29

New targets for drugs: interleukin 17 and its receptors
SUN Chuang-bin,HU Jin-hong,ZHU Quan-gang,LIU Ji-yong,LIU Yan-xia. New targets for drugs: interleukin 17 and its receptors[J]. Foreign Medical Sciences(Section of Pharmarcy), 2008, 35(3): 169-172
Authors:SUN Chuang-bin  HU Jin-hong  ZHU Quan-gang  LIU Ji-yong  LIU Yan-xia
Affiliation:(Department of Pharmacy,Changhai Hospital,the Second Military Medical University,Shanghai 200433,China)
Abstract:
Interleukin 17(IL-17) is a member of potent proinflammatory cytokines secreted by Th17 cell subset. It plays a pathological role in inflammatory and autoimmune diseases for its specific biological effects. IL-17 binds its receptor to transduce signals and produce response. The effective inhibitor of IL-17 receptor-Ig fusion protein showed good therapeutic effects in experiments. This paper reviews the biological effect,signal transduction pathway, associated diseases of IL-17 and its receptors, etc, and provides new ways for IL-17 and its receptor as new drug targets.
Keywords:interleukin 17; receptor  interleukin 17; autoimmune disease  inflammation
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《国际药学研究杂志》浏览原始摘要信息
点击此处可从《国际药学研究杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号